Cargando…

Splice Variants of Androgen Receptor and Prostate Cancer

Over the last ten years, two new-generation hormonal drugs and two chemotherapeutic agents have been approved for the treatment of metastatic castration-resistant prostate cancer. Unfortunately, some patients have primary resistance to them and the others eventually develop secondary resistance. It...

Descripción completa

Detalles Bibliográficos
Autores principales:	Caffo, Orazio, Maines, Francesca, Veccia, Antonello, Kinspergher, Stefania, Galligioni, Enzo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	PAGEPress Publications, Pavia, Italy 2016
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4943095/ https://www.ncbi.nlm.nih.gov/pubmed/27471583 http://dx.doi.org/10.4081/oncol.2016.297

Ejemplares similares

Metastatic castration-resistant prostate cancer in very elderly patients: challenges and solutions
por: Caffo, Orazio, et al.
Publicado: (2016)

Aberrations of DNA Repair Pathways in Prostate Cancer: Future Implications for Clinical Practice?
por: Caffo, Orazio, et al.
Publicado: (2018)

Severe acute respiratory syndrome coronavirus 2 infection in patients with prostate cancer: A critical review
por: Caffo, Orazio, et al.
Publicado: (2021)

Impact of post-implant dosimetric parameters on the quality of life of patients treated with low-dose rate brachytherapy for localised prostate cancer: results of a single-institution study
por: Veccia, Antonello, et al.
Publicado: (2015)

Nasopharyngeal swab or clinical-radiological evidence: the dark side of the moon for cancer patients in the COVID-19 era
por: Veccia, Antonello, et al.
Publicado: (2020)

Impact of KRAS Mutations on Clinical Outcomes of Patients with Advanced Non-Squamous Non-Small Cell Lung Cancer Receiving Anti-PD-1/PD-L1 Therapy
por: Veccia, Antonello, et al.
Publicado: (2022)

Immune Modulation in Prostate Cancer Patients Treated with Androgen Receptor (AR)-Targeted Therapy
por: Conteduca, Vincenza, et al.
Publicado: (2020)

Androgen receptor splice variants and prostate cancer: From bench to bedside
por: Wadosky, Kristine M., et al.
Publicado: (2017)

The Androgen Receptor in Prostate Cancer: Effect of Structure, Ligands and Spliced Variants on Therapy
por: Messner, Elisabeth A., et al.
Publicado: (2020)

Role of androgen receptor splice variants in prostate cancer metastasis
por: Xu, Jin, et al.
Publicado: (2016)

Decoding the androgen receptor splice variants
por: Lu, Changxue, et al.
Publicado: (2013)

Incidence and outcomes of severe acute respiratory syndrome coronavirus 2 infection in patients with metastatic castration-resistant prostate cancer
por: Caffo, Orazio, et al.
Publicado: (2020)

ING Tumour Suppressors and ING Splice Variants as Coregulators of the Androgen Receptor Signalling in Prostate Cancer
por: Melekhova, Anna, et al.
Publicado: (2021)

Ratio of the expression levels of androgen receptor splice variant 7 to androgen receptor in castration refractory prostate cancer
por: Sekine, Yoshitaka, et al.
Publicado: (2021)

Feasibility of abiraterone acetate treatment in patients with metastatic castration-resistant prostate cancer and atrial fibrillation
por: Rauch, Simon, et al.
Publicado: (2016)

Androgen Receptor Splice Variants Contribute to the Upregulation of DNA Repair in Prostate Cancer
por: Tolkach, Yuri, et al.
Publicado: (2022)

Pinostilbene inhibits full-length and splice variant of androgen receptor in prostate cancer
por: Shin, Won Sik, et al.
Publicado: (2023)

Regulation of androgen receptor variants in prostate cancer
por: Zhu, Yezi, et al.
Publicado: (2020)

Beyond Prostate Cancer: An Androgen Receptor Splice Variant Expression in Multiple Malignancies, Non-Cancer Pathologies, and Development
por: Katleba, Kimberley D., et al.
Publicado: (2023)

Identification of Androgen Receptor Splice Variants in the Pten Deficient Murine Prostate Cancer Model
por: Liang, Mengmeng, et al.
Publicado: (2015)

Registered report: androgen receptor splice variants determine taxane sensitivity in prostate cancer
por: Shan, Xiaochuan, et al.
Publicado: (2015)

Replication study: androgen receptor splice variants determine taxane sensitivity in prostate cancer
por: Shan, Xiaochuan, et al.
Publicado: (2018)

Androgen receptor splice variant-7 expression emerges with castration resistance in prostate cancer
por: Sharp, Adam, et al.
Publicado: (2018)

Raddeanin A down‐regulates androgen receptor and its splice variants in prostate cancer
por: Xia, Hongyan, et al.
Publicado: (2019)

Systemic Immune-Inflammation Index Predicts the Clinical Outcome in Patients with mCRPC Treated with Abiraterone
por: Lolli, Cristian, et al.
Publicado: (2016)

Correction: Identification of Androgen Receptor Splice Variants in the Pten Deficient Murine Prostate Cancer Model
por: Liang, Mengmeng, et al.
Publicado: (2016)

Splicing Factors Have an Essential Role in Prostate Cancer Progression and Androgen Receptor Signaling
por: Takayama, Ken-ichi
Publicado: (2019)

The characteristics of androgen receptor splice variant 7 in the treatment of hormonal sensitive prostate cancer: a systematic review and meta-analysis
por: Wang, Zhize, et al.
Publicado: (2020)

Expression of androgen receptor splice variants in clinical breast cancers
por: Hickey, Theresa E., et al.
Publicado: (2015)

Androgen deprivation therapy in castrate-resistant prostate cancer: how important is GnRH agonist backbone therapy?
por: Merseburger, Axel S., et al.
Publicado: (2014)

Androgen receptor and its splice variant, AR-V7, differentially induce mRNA splicing in prostate cancer cells
por: Rana, Manjul, et al.
Publicado: (2021)

Plasma Androgen Receptor in Prostate Cancer
por: Conteduca, Vincenza, et al.
Publicado: (2019)

A Positive Role of c-Myc in Regulating Androgen Receptor and its Splice Variants in Prostate Cancer
por: Bai, Shanshan, et al.
Publicado: (2019)

Inhibiting androgen receptor splice variants with cysteine-selective irreversible covalent inhibitors to treat prostate cancer
por: Thiyagarajan, Thirumagal, et al.
Publicado: (2022)

Ralaniten Sensitizes Enzalutamide-Resistant Prostate Cancer to Ionizing Radiation in Prostate Cancer Cells that Express Androgen Receptor Splice Variants
por: Banuelos, Carmen A., et al.
Publicado: (2020)

Racial Differences in Androgen Receptor (AR) and AR Splice Variants (AR-SVs) Expression in Treatment-Naïve Androgen-Dependent Prostate Cancer
por: Khan, Farhan, et al.
Publicado: (2023)

Role of androgen receptor splice variant 7 (AR-V7) in prostate cancer resistance to 2(nd) generation androgen receptor signaling inhibitors
por: Zhu, Yezi, et al.
Publicado: (2020)

Therapeutic targeting of the androgen receptor (AR) and AR variants in prostate cancer
por: Narayanan, Ramesh
Publicado: (2020)

AR intragenic deletions linked to androgen receptor splice variant expression and activity in models of prostate cancer progression
por: Li, Yingming, et al.
Publicado: (2012)

Expression of Androgen Receptor Splice Variants in Prostate Cancer Bone Metastases is Associated with Castration-Resistance and Short Survival
por: Hörnberg, Emma, et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_eo0s31rsmql6lujcelf2cqjelq